全文获取类型
收费全文 | 867篇 |
免费 | 43篇 |
国内免费 | 92篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 15篇 |
妇产科学 | 1篇 |
基础医学 | 119篇 |
口腔科学 | 9篇 |
临床医学 | 93篇 |
内科学 | 184篇 |
皮肤病学 | 15篇 |
神经病学 | 34篇 |
特种医学 | 27篇 |
外科学 | 46篇 |
综合类 | 18篇 |
预防医学 | 49篇 |
眼科学 | 3篇 |
药学 | 91篇 |
中国医学 | 2篇 |
肿瘤学 | 289篇 |
出版年
2023年 | 2篇 |
2022年 | 6篇 |
2021年 | 16篇 |
2020年 | 17篇 |
2019年 | 19篇 |
2018年 | 17篇 |
2017年 | 14篇 |
2016年 | 10篇 |
2015年 | 17篇 |
2014年 | 29篇 |
2013年 | 41篇 |
2012年 | 48篇 |
2011年 | 48篇 |
2010年 | 42篇 |
2009年 | 29篇 |
2008年 | 44篇 |
2007年 | 107篇 |
2006年 | 63篇 |
2005年 | 48篇 |
2004年 | 30篇 |
2003年 | 22篇 |
2002年 | 24篇 |
2001年 | 32篇 |
2000年 | 34篇 |
1999年 | 28篇 |
1998年 | 29篇 |
1997年 | 17篇 |
1996年 | 14篇 |
1995年 | 20篇 |
1994年 | 26篇 |
1993年 | 16篇 |
1992年 | 17篇 |
1991年 | 13篇 |
1990年 | 16篇 |
1989年 | 14篇 |
1988年 | 10篇 |
1987年 | 4篇 |
1986年 | 4篇 |
1985年 | 2篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1980年 | 1篇 |
1978年 | 2篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1973年 | 1篇 |
1972年 | 2篇 |
排序方式: 共有1002条查询结果,搜索用时 15 毫秒
11.
目的:综合分析目前原发性高血压基因治疗的前景及其面临的主要问题。资料来源:应用计算机检索Pubmed数据库1996-01/2006-01有关原发性高血压基因治疗的文章,检索词“hypertension,genetherapy”,限定文章种类为“English”。同时检索万方数据2000-01/2006-01有关原发性高血压基因治疗的文章,检索词“原发性高血压,基因治疗/疗法”。资料选择:纳入标准:①关于原发性高血压基因治疗策略的研究。②关于基因治疗正义及反义基因的研究。③关于原发性高血压基因治疗载体的研究。排除标准:陈旧或重复性研究及综述。资料提炼:共收集到195篇与原发性高血压基因治疗相关的文献,其中30篇符合纳入标准。资料综合:①原发性高血压基因治疗目前有两种策略,即反义抑制策略和过度表达策略。反义抑制策略减少原发性高血压和心血管病理生理相关的基因转录和翻译;过度表达策略使血压降低相关基因的表达都增加,从而增加舒血管物质的生成使血管舒张。②原发性高血压基因治疗要选择高效转染分裂和非分裂细胞,易于大量制造,无免疫原性,无毒副作用,可载入大分子DNA,能整合进入宿主基因组,且不影响其他基因的载体。③目前面临着原发性高血压靶基因的界定、载体的选择等问题。结论:靶基因的界定,载体的构建和基因转移法是原发性高血压基因治疗的关键,基因治疗可减少传统药物治疗带来的副作用,降低原发性高血压的发病率,甚至治愈原发性高血压。 相似文献
12.
Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor 总被引:13,自引:4,他引:13
Blay JY; Burdin N; Rousset F; Lenoir G; Biron P; Philip T; Banchereau J; Favrot MC 《Blood》1993,82(7):2169-2174
Serum interleukin-10 (IL-10) was measured retrospectively in 153 patients with a fully documented history of non-Hodgkin's lymphoma (NHL) using an enzyme-linked immunosorbent assay (ELISA) detecting both human IL-10 and the Epstein-Barr virus (EBV) molecule BCRF1/viral IL- 10. IL-10 was detectable in 47 (46%) of the 101 patients with active NHL, 3 of 52 (6%) patients in first partial or complete response, and none of the 60 healthy blood donors. Serum IL-10 was detectable with a similar frequency in all subtypes of NHL and in all clinical stages, as well as in EBV-seropositive and EBV-negative patients. In patients with intermediate or high-grade NHL, the presence of detectable serum IL-10 at diagnosis was correlated to a significantly shorter overall (P = .025) and progression-free (P = .030) survival. Patients with stage IV disease and detectable serum IL-10 had a particularly poor prognosis (4 years of survival: 0%). Multivariate analysis showed that IL-10 was an independent prognosis factor. These results indicate that IL-10 is detectable in a subgroup of patients with active NHL and correlates to a poor survival in patients with intermediate or high-grade NHL. 相似文献
13.
静息状态脑功能网络的研究及应用 总被引:1,自引:0,他引:1
目的:对静息状态网络的研究方法、初步的研究成果等作以介绍,并结合静息状态网络在阿尔茨海默病早期预警中的应用,介绍静息状态脑网络的应用。资料来源:应用计算机检索PubMed1980-01/2006-12与静息状态网络相关的文献,检索词“restingstate,functional connectivity”,并限定文献语言种类为“English”;同时计算机检索万方数据库1995-01/2006-12有关方面的文献,检索词为“静息,功能连接,阿尔茨海默病”,并限定语言种类为中文。资料选择:对资料进行初审,选取包括静息状态的相关文献,开始查找原文。纳入标准:①有关静息状态脑网络和功能连接的研究。②有关阿尔茨海默病的研究。排除标准:重复研究。资料提炼:共收集到53篇有关静息状态网络方面的研究,排除23篇重复性研究,30篇符合要求。资料综合:近年来,研究者发现大脑处于无任务的静息状态时,仍然存在着某种功能活动。这些现象表明大脑在静息状态时可能存在有组织的网络。这有助于对人脑高级意识和某些认知疾病的研究,因此,有关这方面的工作越来越受到人们的重视。结论:对静息状态网络的本质和规律的研究还很有限,对这个网络所支持的精确的功能还有待于进一步研究。 相似文献
14.
15.
I. Annesi‐Maesano C. Zhou N. Baïz S. Banerjee D. Andr Charpin D. Caillaud F. de Blay C. Raherison F. Lavaud 《Allergy》2013,68(11):1471-1474
We investigated the relationships of behavioural problems as assessed using the standardized Strengths and Difficulties Questionnaire (SDQ) to asthma in view of improving asthma management. Six thousand eight hundred and eighty children (mean age 10.4 years, male: 49%) were recruited in the French 6 Cities Study. Children with abnormal or borderline emotional symptoms (internalizing problems) or conduct problems (externalizing problems) were more asthmatic than others (P < 0.01). Compared to being normal, abnormal emotional symptoms or conduct problems were found to be related to mild‐to‐moderate persistent asthma (logistic model adjusted odds ratio = 1.55 (95% CI = 1.26–1.90) and 1.42 (95% CI = 1.17–1.71), respectively) and to early‐onset asthma (Cox's model Adjusted Hazard Risk = 1.60 (95% CI = 1.27–2.01) and 1.34 (95% CI = 1.05–1.70). Borderline conduct problems were found to be negatively related to parents' knowledge on how to prevent asthma attacks, compared to normal conduct problems [adjusted OR = 0.51 (95% CI = 0.31–0.85)]. Further data are needed to better understand the involvement of behavioural problems in childhood asthma according to phenotypes. 相似文献
16.
17.
Exposure to allergens could be either a risk factor of sensitization and nonspecific hyperresponsiveness in genetically predisposed patients or a risk of onset of asthma attack in certain allergic asthma. During the past 20 years, in western countries the houses have become higher and the number of furred pets have increased and have been more kept inside the house which makes probable that exposure to indoor aeroallergen has increased. The development of new methods of allergen measurements allows a more precise identification of allergen source and reservoirs, an assessment of allergen exposure and a monitoring of allergen eviction methods. Concerning mite allergens, controlled studies which showed a clinical efficacy are those with a global mite eviction and at least a 6 months follow-up for cat and dog allergens, high efficiency-filters air cleaners or vacuum-cleaners are able to reduce airborne cat or dog allergen levels. According to the increasing number of papers about allergen eviction, it seems logical to propose allergen eviction as "first line treatment" of allergic asthma. In the future, it would be interesting to develop biological markers to identify more accurately patients who have a clinical improvement after allergen eviction. 相似文献
18.
Le Blay G Blottière HM Ferrier L Le Foll E Bonnet C Galmiche JP Cherbut C 《Digestive diseases and sciences》2000,45(8):1623-1630
Short-chain fatty acids are the main end products of bacterial fermentation of carbohydrates. Their role on the metabolism and biology of colonocytes is now well characterized. However, the functional consequences of their presence on intestinal smooth muscle cells remain poorly studied. We aimed to assess the effect of different short-chain fatty acids on ileal and colonic smooth muscle cells in primary culture and on A7R5 line. Butyrate (above 0.1 mM) inhibited A7R5 cell proliferation, while at low concentration (0.05 to 0.5 mM) butyrate significantly stimulated the proliferation of ileal and colonic myocytes in primary culture. An inhibition was observed at higher concentrations. Collagenous and noncollagenous protein synthesis was stimulated by butyrate. Moreover, butyrate stimulated actin and myosin expression. Thus, butyrate, which is produced by dietary fiber fermentation, may affect intestinal muscles by directly acting at the molecular level on myocytes. 相似文献
19.
Solary E; Witz B; Caillot D; Moreau P; Desablens B; Cahn JY; Sadoun A; Pignon B; Berthou C; Maloisel F; Guyotat D; Casassus P; Ifrah N; Lamy Y; Audhuy B; Colombat P; Harousseau JL 《Blood》1996,88(4):1198-1205
A phase III prospective randomized multicenter study was performed to determine whether quinine could improve the response rate of poor-risk acute leukemias (ALs) to standard chemotherapy including a multidrug resistance (MDR)-related cytotoxic agent. The rationale of the study was based on the negative prognostic value of MDR phenotype in ALs and the ability of quinine to reverse this phenotype both in vitro and ex vivo. Three hundred fifteen patients (median age, 49 years; range, 16 to 65) with relapsed (n = 108) or refractory (n = 32) acute myeloblastic leukemia (AML), relapsed (n = 27) or refractory (n = 9) acute lymphoblastic leukemia (ALL), secondary AL (n = 22) or blastic transformation of myelodysplastic syndrome ([MDS] n = 74) or myeloproliferative syndrome ([MPS] n = 43) were randomly assigned to receive mitoxantrone ([MXN] 12 mg/m2/d, days 2 to 5) and cytarabine ([Ara-C] 1 g/m2/12 h, days 1 to 5) alone or in combination with quinine (30 mg/kg/d, days 1 to 5; continuous intravenous infusion beginning 24 hours before MXN infusion). Side effects of quinine were observed in 56 of 161 quinine-treated patients and disappeared in all but four cases after one or two 20% dose decreases. Sera from quinine-treated patients showed increased MXN uptake in an MDR-positive cell line compared with matched sera obtained before quinine infusion. Quinine induced a significant increase in the incidence of nausea, vomiting, mucositis, and cardiac toxicity. A complete response (CR) was observed in 85 of 161 patients (52.8%) from the quinine-treated group versus 70 of 154 patients (45.5%) in the control group (P = .19). The most important differences between quinine and control group CR rates were observed in patients with refractory AMLs and blastic transformation of MDS and MPS. The CR rate was higher in P-glycoprotein-positive cases, although the difference was not significant. Failure of the regimen due to blastic persistence or blast number increase was higher in the control group (61 of 154 patients) than in the quinine group (45 of 161, P = .04). Early death was observed in eight cases (four in each arm) and death in aplasia in 27 cases (20 in quinine group v seven in control group, P = .01). The significant increase of toxicity in the quinine arm could have masked the clinical benefit of MDR reversion in poor- risk ALs. 相似文献
20.
Fred Stephen Sarfo Albert Akpalu Ansumana Bockarie Lambert Appiah Samuel Blay Nguah Nana Kwame Ayisi-Boateng Sheila Adamu Christiana Neizer Agnes Arthur Richard Nyamekye Kwabena Agyenim-Boateng Raelle Tagge Nathaniel Adusei-Mensah Michael Ampofo Ruth Laryea Arti Singh John Humphry Amuasi Bruce Ovbiagele 《Journal of stroke and cerebrovascular diseases》2021,30(8):105888
ObjectivesThe Sub-Saharan African (SSA) region now has the highest estimated effect size of hypertension for stroke causation worldwide. An urgent priority for countries in SSA is to develop and test self-management interventions to control hypertension among those at highest risk of adverse outcomes. Thus the overall objective of the Phone-based Intervention under Nurse Guidance after Stroke II study (PINGS-2) is to deploy a hybrid study design to assess the efficacy of a theoretical-model-based, mHealth technology-centered, nurse-led, multi-level integrated approach to improve longer term blood pressure (BP) control among stroke survivors.Materials and methodsA phase III randomized controlled trial involving 500 recent stroke survivors to be enrolled across 10 Ghanaian hospitals. Using a computer-generated sequence, patients will be randomly assigned 1:1 into the intervention or usual care arms. The intervention comprises of (i) home BP monitoring at least once weekly with nurse navigation for high domiciliary BP readings; (2) medication reminders using mobile phone alerts and (3) education on hypertension and stroke delivered once weekly via audio messages in preferred local dialects. The intervention will last for 12 months. The control group will receive usual care as determined by local guidelines. The primary outcome is the proportion of patients with systolic BP <140 mm Hg at 12 months. Secondary outcomes will include medication adherence, self-management of hypertension, major adverse cardiovascular events, health related quality of life and implementation outcomes.ConclusionAn effective PINGS intervention can potentially be scaled up and disseminated across healthcare systems in low-and-middle income countries challenged with resource constraints to reduce poor outcomes among stroke survivors. 相似文献